X-COR Therapeutics is focused on developing innovative therapies for patients with serious diseases, particularly in the field of gene therapy. The company utilizes advanced technologies to create targeted treatments that aim to address the underlying causes of genetic disorders. Their pipeline includes a range of product candidates designed to deliver therapeutic genes directly to affected tissues, enhancing the body's ability to produce necessary proteins and restore normal function. This approach not only aims to improve patient outcomes but also seeks to provide long-lasting solutions for chronic conditions.

The scientific foundation of X-COR Therapeutics is built on a deep understanding of molecular biology and genetic engineering. The company employs cutting-edge techniques to ensure precise delivery and expression of therapeutic genes, minimizing potential side effects and maximizing efficacy. Their research emphasizes the importance of safety and effectiveness, with a commitment to rigorous preclinical and clinical testing. By leveraging these technologies, X-COR Therapeutics aims to transform the treatment landscape for patients suffering from genetic diseases, ultimately improving their quality of life.

United States

X-COR Therapeutics is a medical device company creating the first commercially available CO2 removal device that uses ultra-low-blood flows for a cheaper, safer, and more accessible treatment for acute respiratory failure.

X-COR Therapeutics

Company Details